EXACT Sciences

Yahoo Finance • 19 days ago

Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences

Abbott Laboratories (NYSE:ABT) is one of the Best Conservative Stocks to Buy Right Now.On March 23, the company announced that it had completed the acquisition of Exact Sciences. As a result of this, Abbott Laboratories (NYSE:ABT) is now a... Full story

Yahoo Finance • 23 days ago

Clearwater Analytics Stock Lands $37 Million Investment Amid 77% ARR Growth Surge and Pending Buyout

On February 17, 2026, Fort Baker Capital Management disclosed a new position in Clearwater Analytics(NYSE:CWAN), acquiring 1,529,288 shares worth $36.89 million in the fourth quarter. What happened According to a filing with the Securiti... Full story

Yahoo Finance • 23 days ago

This $19.8 Million Bet on Commvault Comes Amid a 51% Drop. Here’s What Investors Should Know

Key Points Cinctive Capital Management initiated a new position by acquiring 157,815 shares of Commvault Systems in the fourth quarter. The quarter-end position value increased by $19.78 million as a result of the new portfolio addition.... Full story

Yahoo Finance • 25 days ago

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Announcement follows receipt of all regulatory clearances necessary for closing Transaction enables Abbott to enter and lead in fast-growing cancer screening and diagnostics segments, serving millions of additional people ABBOTT PARK, Ill... Full story

Yahoo Finance • 2 months ago

Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025. On February 20, the company announced that its shareholders had approved th... Full story

Yahoo Finance • 2 months ago

Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time

Tilray Brands(NASDAQ: TLRY), like many other cannabis stocks, has taken investors on a wild roller-coaster ride the past few years, though for the most part, that ride has been downward. The stock soared by more than 10 times in the months... Full story

Yahoo Finance • 2 months ago

Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo Personalized Medicine Market Poised for Tremendous Growth by 2033The global personalized medicine market, valued at approximately US$ 585.53 billion in 2026, is projected to soar to nearly US$ 1.00 trillion by 2033. A report... Full story

Yahoo Finance • 2 months ago

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts" report has been added to Rese... Full story

Yahoo Finance • 2 months ago

Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting

Exact Sciences logo Key Points Merger with Abbott approved: Stockholders voted to adopt the November 19, 2025 merger agreement to combine Exact Sciences with Abbott, while the advisory executive compensation proposal tied to the deal was... Full story

Yahoo Finance • 2 months ago

Exact Sciences shareholders approve acquisition by Abbott

* Exact Sciences (EXAS [https://seekingalpha.com/symbol/EXAS]) said [https://seekingalpha.com/pr/20407907-exact-sciences-stockholders-approve-acquisition-by-abbott] on Friday that shareholders approved the proposed acquisition by Abbott,... Full story

Yahoo Finance • 2 months ago

Exact Sciences Stockholders Approve Acquisition by Abbott

MADISON, Wis., February 20, 2026--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) ("Exact Sciences"), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the propos... Full story

Yahoo Finance • 2 months ago

How The Abbott Offer Is Rewriting The Story For Exact Sciences (EXAS)

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Exact Sciences’ story has shifted toward the US$105 per share Abbott offer becoming the key anchor for what many inves... Full story

Yahoo Finance • 2 months ago

Paul Tudor Jones Makes Significant Moves with iShares Core S&P 500 ETF

This article first appeared on GuruFocus. Exploring the Latest 13F Filing and Investment Strategies Paul Tudor Jones (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing insights into his invest... Full story

Yahoo Finance • 2 months ago

Small Cap ETFs: VB Boasts Lower Fees, While ISCB Sports a Higher Dividend Yield

The iShares Morningstar Small-Cap ETF ((NYSEMKT:ISCB)) and Vanguard Small-Cap ETF ((NYSEMKT:VB)) both offer broad U.S. small-cap exposure, but ISCB delivered stronger recent returns and holds more names, while VB is far larger, more liquid... Full story

Yahoo Finance • 2 months ago

George Soros Reduces Stake in Smurfit WestRock PLC by 68.99%

This article first appeared on GuruFocus. Insight into Soros's Strategic Moves in Q4 2025 George Soros (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing insights into his investment moves dur... Full story

Yahoo Finance • 2 months ago

Soros Fund ups stake in Microsoft, NVIDIA, Apple as part of Q4 moves

[Microsoft logo] jewhyte/iStock Editorial via Getty Images Hungarian-American investor George Soros's Soros Fund increased its stake in Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]), NVIDIA (NVDA [https://seekingalpha.com/symbol... Full story

Yahoo Finance • 2 months ago

Is It Too Late To Consider Exact Sciences (EXAS) After The US$105 Abbott Offer

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are wondering whether Exact Sciences at around US$103 a share still offers value, you are not alone. This article is... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC is Investigating Whether CTRA, EXAS, NFBK are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC is Investigating SKYT, EXAS, GORO, MOVE on Behalf of Shareholders

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

Multiple Tailwinds Lifted Exact Sciences Corporation (EXAS) in 2025

Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Fund focuses on long-term, competitively positioned companies that are... Full story